AsiaMedic（505）年次報告書
ASIAMEDIC LIMITED ・ シンガポール取引所カタリスト上場。業種は Health and Social Services。本頁はこの会社の年次報告書・サステナビリティ報告書を整理し、PDF は SGX が直接提供します。
AsiaMedic の事業内容
Headquartered in Singapore and listed on the Catalist Board of the Singapore
Stock Exchange, AsiaMedic Limited is a premier healthcare provider that focuses
on the management of clinical services in the fields of disease prevention,
early illness detection and advanced diagnostics. Its team of highly qualified
and reputable professionals provides clinical and management services both in
Singapore and overseas.
The services provided by AsiaMedic include but are not limited to health-risk
assessments and screening, general and subspecialty imaging such as MRI and CT
Scans for cardiovascular, neuroradiological, ENT and musculoskeletal imaging;
PET/CT imaging for diagnosis, staging, localisation and monitoring progress of
cancer.
Driven by its commitment to the core values of competence, care, convenience
and collaboration, AsiaMedic has built up a strong brand name for delivering
positive patient outcomes and high-quality care for its patients from Singapore
and around the region.
Apart from Singapore, AsiaMedic has a growing presence in key growth markets
such as China, Indonesia, Vietnam and Russia. Recognising the increasing demand
for quality healthcare services in Asia and the Middle East, AsiaMedic expanded
into the provision of international healthcare consultancy and management
services in 2009.
As an endorsement of its strengths and track record in the regional healthcare
services industry, AsiaMedic was awarded two high-profiled turnkey projects in
Abu Dhabi by Mubadala Healthcare, a division of Mubadala Development Co. and
owned by the Government of the Emirate of Abu Dhabi. The projects were
successfully completed and handed over in early 2012.
Having tested and proven its healthcare services business model in Singapore
and the region, AsiaMedic is developing more innovative healthcare services in
selected markets for its next stage of growth.
AsiaMedic の開示（年度別）
AsiaMedic の年次報告書について
AsiaMedic（505）の年次報告書はどこでダウンロードできますか？
上の表の各年度がシンガポール取引所（SGX）に提出された PDF へ直接リンクしています。現在 12 件を収録（2014〜2025 年度）。
シンガポール上場企業に四半期報告はありますか？
多くはありません。SGX は 2020 年に四半期報告の義務を廃止しリスクベース制度に移行——一定の基準に該当する会社だけが四半期提出を続けます。多くの会社は半期報告と年次報告書の年 2 回です。本頁の四半期報告が少ないのは制度どおりで、データの欠落ではありません。
サステナビリティ報告書とは何ですか？
SGX は 2016 年から上場企業に環境・社会・ガバナンス（ESG）を扱うサステナビリティ報告書の公表を義務付けています。年次報告書とは別の文書で、本頁は両方を収録します。
メインボードとカタリストは何が違いますか？
カタリストは上場基準が低く成長期の中小企業向けで、スポンサー制度が監督します。メインボードは利益・時価総額の基準が高い市場です。開示義務はおおむね同等です。